<SEC-DOCUMENT>0001213900-19-002029-index.html : 20190211
<SEC-HEADER>0001213900-19-002029.hdr.sgml : 20190211
<ACCEPTANCE-DATETIME>20190211080034
ACCESSION NUMBER:		0001213900-19-002029
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20190206
ITEM INFORMATION:		Entry into a Material Definitive Agreement
FILED AS OF DATE:		20190211
DATE AS OF CHANGE:		20190211

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RELMADA THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001553643
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				455401931
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-55347
		FILM NUMBER:		19581928

	BUSINESS ADDRESS:	
		STREET 1:		750 THIRD AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		212-547-9591

	MAIL ADDRESS:	
		STREET 1:		750 THIRD AVENUE, 9TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CAMP NINE, INC.
		DATE OF NAME CHANGE:	20120706
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k020519_relmadatherap.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k020519_relmadatherap.htm

</DOCUMENT>
</SEC-DOCUMENT>